BioSpace News Archive

Business

BrickBio Announces Rapid V2, eCLIC™, Chemistry and Cytokine External Partner Collaboration

BrickBio announced a rapid next-generation conjugation chemistry, eCLIC™

November 2, 2021
·
3 min read
Drug Development

Ionis initiates pivotal Phase 3 clinical study of olezarsen in patients with severe hypertriglyceridemia

Ionis Pharmaceuticals, Inc. announced today the initiation of CORE, the second Phase 3 clinical study of olezarsen, formerly known as IONIS-APOCIII-LRx.

November 2, 2021
·
4 min read
Business

Concert Pharmaceuticals to Report Third Quarter 2021 Results on November 9, 2021

Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will report its financial results for the third quarter of 2021, on Tuesday, November 9, 2021, before the U.S. financial markets open.

November 2, 2021
·
1 min read
BioCapital

Valted Seq Raises $10.5 Million in Seed Funding Round

Valted Seq, a biotechnology company focused on the genetic elucidation of neurodegenerative disease pathways to accelerate development of new therapeutics and diagnostics, announced the completion of a seed fundraising round totaling $10.5 million.

November 2, 2021
·
2 min read
Pharm Country

Bruker Announces Major Advances in CCS-Enabled 4D Proteomics at ASMS

Bruker PaSER™ software now incorporates transformative CCS-enabled DIA-NN deep neural network learning with breakthrough dia-PASEF capabilities to identify

November 2, 2021
·
8 min read
Business

ADC Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Updates

ZYNLONTA ® (loncastuximab tesirine-lpyl) third quarter 2021 net sales of $13.1 million

November 2, 2021
·
19 min read
Business

Acorda Third Quarter 2021 Update: Webcast Scheduled for November 9, 2021

Acorda Therapeutics, Inc. (NASDAQ: ACOR) will host a Webcast in conjunction with its third quarter 2021 update and financial results on Tuesday, November 9, at 4:30 p.m. ET.

November 2, 2021
·
4 min read
Business

Catalent, Inc. Reports First Quarter Fiscal 2022 Results

Catalent, Inc. today announced financial results for the first quarter of fiscal 2022, which ended September 30, 2021.

November 2, 2021
·
24 min read
Innovative Embolic Device Shows Promise for Interventional Oncology Drug Delivery

Fluidx Medical Technology announced that a next-generation, doxorubicin-loaded GPX Embolic Device was featured at the recent Symposium on Clinical Interventional Oncology (CIO) Conference

November 2, 2021
·
2 min read
Business

Acerus to Report Q3-2021 Financial Results and Host Investor Call

Acerus Pharmaceuticals Corporation will announce its third quarter 2021 financial and operating results on Tuesday, November 9, 2021 before the market opens.

November 2, 2021
·
1 min read